Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.73 |
| ▸ | LMNA | P02545 | 6/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 4/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | STAT3 | P40763 | 1/20 | 0.58 |
| ▸ | LTA4H | P09960 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.56 |
| ▸ | RELA | Q04206 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14423493 | 0.91 | SMN1; SMN2 (0.85) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A | |
| SCHEMBL501944 | 0.91 | SMN1; SMN2 (0.85) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A | |
| SCHEMBL5374402 | 0.91 | SMN1; SMN2 (0.85) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A | |
| SCHEMBL92599 | 0.91 | SMN1; SMN2 (0.85) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A | |
| SCHEMBL741950 | 0.90 | SMN1; SMN2 (0.66) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A | |
| SCHEMBL502183 | 0.88 | SMN1; SMN2 (0.75) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A | |
| SCHEMBL501859 | 0.87 | SMN1; SMN2 (0.74) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A | |
| SCHEMBL352045 | 0.86 | SMN1; SMN2 (0.96) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A | |
| SCHEMBL351186 | 0.84 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A | |
| SCHEMBL29924240 | 0.84 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNATDP1L3MBTL1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12497382-B2 | GLP-1R modulating compounds | GILEAD SCIENCES, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| EP-4605398-A1 | BICYCLIC FERROPORTIN INHIBITORS | Vifor (International) AG (CH) | 2025-08-27 | — | — | EP | disclosed |
| WO-2024083980-A1 | BICYCLIC FERROPORTIN INHIBITORS | VIFOR (INTERNATIONAL) AG (CH) | 2024-04-25 | — | — | WO | disclosed |
| US-20230391747-A1 | GLP-1R MODULATING COMPOUNDS | GILEAD SCIENCES, INC. | 2023-12-07 | — | — | US | disclosed |
| EP-4271674-A1 | CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2023-11-08 | — | — | EP | disclosed |
| US-11702404-B2 | GLP-1R modulating compounds | GILEAD SCIENCES, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| US-20230152692-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| WO-2022225914-A1 | CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2022-10-27 | — | — | WO | disclosed |
| CN-114630823-A | GLP-1R modulating compounds | 吉利德科学公司 | 2022-06-14 | — | — | CN | disclosed |
| US-11279681-B2 | 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors | VALO HEALTH, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| CN-102084535-B | Dye-sensitized photoelectric conversion element | PECCELL TECHNOLOGIES INC | 2014-07-02 | — | — | CN | disclosed |
| WO-2013026563-A1 | ADDITIVES FOR DYE-SENSITIZED SOLAR CELLS | MERCK PATENT GMBH (DE) | 2013-02-28 | — | — | WO | disclosed |
| WO-2013024119-A1 | RUTHENIUM-BASED COMPLEX CATALYSTS | THE GOVERNING COUNCIL OF UNIVERSITY OF TORONTO (CA) | 2013-02-21 | — | — | WO | disclosed |
| CN-102084535-A | Dye-sensitized photoelectric conversion element | PECCELL TECHNOLOGIES INC | 2011-06-01 | — | — | CN | disclosed |
| US-20110041915-A1 | DYE-SENSITIZED PHOTOELECTRIC CONVERSION ELEMENT | PECCELL TECHNOLOGIES, INC. (JP) | 2011-02-24 | — | — | US | disclosed |
| EP-2276103-A1 | DYE-SENSITIZED PHOTOELECTRIC CONVERSION ELEMENT | Peccell Technologies Inc (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-7252925-B2 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-08-07 | — | — | US | disclosed |
| US-7252925-B2 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-08-07 | — | — | US | disclosed |
| US-7252925-B2 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-08-07 | — | — | US | disclosed |
| US-20050095533-A1 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. | 2005-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11279681-B2 | 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors | HDAC1, HDAC4, HDAC2 | SMN1; SMN2 1067/4885LMNA 1023/4885TDP1 666/4885 |
| US-11702404-B2 | GLP-1R modulating compounds | GLP1R, GIPR, GPR119 | SMN1; SMN2 1956/4885LMNA 3309/4885TDP1 3351/4885 |
| US-20230391747-A1 | GLP-1R MODULATING COMPOUNDS | GLP1R, GIPR, GPR119 | SMN1; SMN2 1956/4885LMNA 3309/4885TDP1 3351/4885 |
| US-12497382-B2 | GLP-1R modulating compounds | GLP1R, GIPR, GPR119 | SMN1; SMN2 1956/4885LMNA 3309/4885TDP1 3351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.